Memed S.A

Memed S. A. is a Brazilian digital health company that enhances healthcare delivery by providing an electronic prescription platform for doctors and pharmacies, improving efficiency and communication. Founded in 2012, Memed S.

A. is headquartered in Sao Paulo, Brazil. The company operates a digital platform that connects healthcare providers with patients, allowing for electronic prescriptions. The firm has completed 6 deals, with the most recent funding round being a Series B, where they raised BRL 20.

000 mn in April 2021 led by DNA Capital. The founders of Memed include Marcel Ribeiro, René Moraes, Rica Moraes, and Sathvika Bodhapati, with Rica Moraes and Sathvika Bodhapati currently serving as CEO. Memed specializes in digital health solutions aimed at streamlining the healthcare experience. Its primary offering is a digital prescription platform that enables doctors to issue prescriptions electronically, improving efficiency and safety.

With over 262,000 registered doctors and more than 80,000 pharmacies in Brazil, Memed facilitates millions of prescriptions monthly, ensuring seamless communication about patient care and treatment plans. For the year 2019, Memed reported a revenue of BRL 102,026. 2 and an EBITDA of BRL -1,236,309. 1.

The company generates income through partnerships with healthcare providers, pharmacies, and software companies, utilizing a model that includes subscription services and transactional fees related to prescription fulfillment. In April 2021, DNA Capital acquired Memed S. A. as part of its strategy to enhance digital health offerings in Brazil.

The company plans to leverage the recent funding of BRL 20. 000 mn to expand its platform capabilities and potentially explore new markets. Specific future product launches or expansion plans have not yet been disclosed.